Abstract The D Va (Hus) was previously investigated through cDNA analysis, which revealed an RHD-CE(5)-D hybrid allele. However, the 5' and 3' breakpoints remain unknown. In this article, gene recombinations between the RHD and RHCE alleles were investigated by a combination approach of a sequence-specific primer PCR (PCR-SSP) and an RHD full-length coding region sequencing method on two Chinese subjects with weak D phenotypes. The hybrid Rhesus box of each individual was also investigated through an established PCR-based method. As a result, two partial D phenotypes, D Va (Hus) and D VI type III, were identified, each carrying one hybrid RHD-CE-D allele. The two samples were also serotyped with Rh phenotypes of DccEe and DCcee, respectively. Other sequencing analyses of the D Va (Hus) sample showed that the sequence of intron 4 is identical with RHD, whereas the whole sequence of exon 5 and intron 5 is identical with RHCE except for seven polymorphisms in the intron 5. We may concluded that in the case of this Chinese D Va (Hus), the whole exon 5 and complete intron 5 of a total segment of 1801 nucleotides were replaced by RHCE suggesting that the breakpoints of the replaced region are the 5' end of the exon 5 and the 3' end of the intron 5.
Introduction
The Rhesus blood group (Rh) is the most complex of the blood group systems. Rh antigens are encoded by two closely linked homologous genes, RHD and RHCE, encoding the antigens of D and CcEe, respectively. A normal D antigen serologically comprises a mosaic of at least nine antigenic epitopes (Lomas et al. 1989; Legler et al. 2000) . The lack of expression of some of the epitopes at the surface of red blood cells defines the D category, or partial D phenotype. Based on the reactivity with anti-D sera from immunized partial D carriers or differential monoclonal anti-D antibodies, partial D phenotypes have been classified into six distinct categories-D II to D VII (Tippett et al. 1996 (Rouillac et al. 1995; Omi et al. 1999; Hyodo et al. 2000) . D category VI is subdivided into type I, type II, and, recently, type III (Wagner et al. 1998 ).
Subjects and methods
monoclonal IgM+IgG blend regent, IgM: clone 175-2, IgG: Clone 415 1E4, Dominion Biologicals Limited, Nova Scotia, Canada) but positive by indirect antiglobulin test (IAT). The two samples were then defined as weak D phenotypes. Rh C, c, E, and e phenotypes were tested through IgM monoclonal antibodies derived from human/murine heterohybridoma cell lines (anti-C MS24, anti-E MS12, anti-c MS33, anti-e MS16, Immucor Diagnostik GmbH, Roedermark, Germany).
The RHD and RHCE were genotyped through a PCR-SSP method that detects exons 3-7 and 9-10 of RHD, exons 1 and 2 of RHCc, and exon 5 of RHEe (Lan et al. 2000) . Full-length RHD coding region was sequenced according to a published method (Legler et al. 2001) . Briefly, ten exons of RHD were amplified separately with ten pairs of RHD-specific primers that target the complementary sequences in introns. The PCR products were purified using Microcon-PCR Kit (Millipore, Bedford, MA, USA) and submitted to direct sequencing through a BigDye Terminator Cycle Standard method (ABI Prism 3100 DNA Sequencer, Applied Biosystems, Foster City, CA, USA). In addition, the numbers of the RHD gene in each individual were determined through a PCRbased method by specific amplification of the hybrid Rhesus boxes (Perco et al. 2003) .
The entire length of intron 4 and intron 5 on sample-a was also direct sequenced. By reference to the RHD coding sequence (AJ299023 and AJ299024), a pair of primers was chosen to amplify the intron 4 of RHD/RHCE (Sense primer, 5'-AACGATACCC AGTTTGTCTG-3', position 606-625 of RHD; antisense primer, 5'-ATGACCCTGAGATGGCTGT-3', position 769-751). Intron 5 was amplified with primers D5b-U2 and D6-L (Shao et al. 2002) . PCRs were performed in a volume of 25 ll with 50-100 ng genomic DNA, 1 U of DNA polymerase, 200 lM dNTPs, 6.25 pmol of each primer, and 1.5 mM MgCl 2 in a buffer provided by the manufacturer (AmpliTaq Gold, Applied Biosystems, Foster City, CA, USA). Thirty cycles for intron 4 amplification or 40 cycles for intron 5 amplification were performed on a thermocycler PE 9700 (GeneAmp PCR system, Applied Biosystems, Foster City, CA, USA) under the following conditions: denaturation at 95°C for 10 min, following cycles of 94°C for 20 s, 58°C for 30 s, and 72°C for 2 min (for intron 4 amplification) or 5 minutes (for intron 5 amplification), last extension at 72°C for 5 min.
Results
The samples were phenotyped D+C-c+E+e+ (sample-a) and C+c+E-e+ (sample-b), respectively, In PCR-SSP, sample-a was detected negative for exon 5 of RHD, whereas all other exons (exons 3, 4, 6, 7, 9, 10) tested positive. Sample-b was negative for exons 3-6 and positive for exons 7, 9, and 10 of RHD. The RHCE detections in both samples showed a consistent result with serological tests. For sample-a, the sequencing results demonstrated that the whole exon 5 was identical with the exon 5 of RHCE (RHE, 676C), while all other exons (exons 1-4 and 6-10) were the same as normal RHD. Therefore, combined with the result of the the RHD zygosity test, sample-a was a partial D phenotype D Va (Hus) with RHD-CE(5)-D allele in cDE haplotype assuming the RHcE and RHD in cis (cDE/cde). For sample-b, the sequences of detected exons (exons 1-2 and 7-10) were the same as RHD, which were determined both serologically and genotypically as category D VI type III carrying a hybrid allele RHD-CE(3-6)-D (CDe/cde).
The D VI type III was previously investigated through both cDNA and genomic DNA. The D Va (Hus), however, was only analyzed with mRNA. To elucidate the breakpoints of the hybrid allele in this D category, whole intron 4 and intron 5 were sequenced. The results showed that the sequence of intron 4 was identical to RHD, while all RHD/RHCE polymorphisms (a total of 28) in intron 5 were the same as RHCE (GenBank AB035197) but with seven novel polymorphisms (EMBL/GenBank/DDBJ nucleotide sequence database accession number AY330698): 23-25(GCA)2, 98G>A, 168-169insG, 205-206insT, 494-495insA, 1256-1257 insC, and 1347G>T, which distribute to the whole length of intron 5. Our results indicated that the whole exon 5 and complete intron 5 of a total segment of 1,801 nucleotides were replaced by RHCE in D Va (Hus), suggesting that the breakpoints of the replaced region are the 5' end of exon 5 and the 3' end of intron 5 (Fig. 1) . Va Ce in whites and Japanese (Tippett et al. 1996; Wagner et al. 1998; Legler et al. 2000) . Interestingly, in our case, D Va was expressed in a D Va cE haplotype (indicating gene conversion happened in cis), which is rare in other populations.
Discussion
The 5' hybrid site of the RHCE-derived genomic sequences of the D VI type III allele, RHD-CE(3-6)-D, was located in the middle of intron 2, while the 3' breakpoint was located in intron 6 between +360 bp and +963 bp (Wagner et al. 1998 ). Our results demonstrated that the 5' hybrid point of the replaced exon-5-intron-5 region in D Va (Hus) was between position )246 of intron 4 (the first RHD/RHCE polymorphism from the 3' end, AB041536 and AB041535) and 667 of RHD exon 5, and the 3' hybrid site would be between +1497 of intron 5 (the first RHD/RHCE polymorphism from the 3' end, AB035198 and AB035197) and 916 of RHD exon 5, which suggests a replaced region of the 5' end of exon 5 to the 3' end of intron 5.
